Description
Composition:
Each hard gelatin capsule contains
Rosuvastatin Calcium IP
Eq. to Rosuvastatin…..20mg/10mg
(as Film coated tablet)
Aspirin IP ….75mg
(As enteric coated tablet)
Mechanism:
Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis. Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL). The overall effect is a decrease in plasma LDL and VLDL.
Aspirin and other non-steroid anti-inflammatory drugs (NSAIDs) inhibit the activity of the enzyme now called cyclooxygenase (COX) which leads to the formation of prostaglandins (PGs) that cause inflammation, swelling, pain and fever.
Indication:
For the treatment of dyslipidemia associated with atherosclerotic arterial disease with risk of myocardial Infarction , stroke or peripheral vascular disease.
Dosage:
One capsule once daily or to be taken in a dose and duration as directed by the Physician.